MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate th
Storage Temp
Store at -20°C
Shipped In
Ice chest + Ice pads
Grade
Moligand™
Action Type
AGONIST
Mechanism of action
Glucose-dependent insulinotropic receptor agonist
Note
卖完停产,不再备货
Product Description
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
1.Alper P, Azimioara M, Cow C, Mutnick D, Nikulin V, Michellys PY, Wang Z, Reding E, Paliotti M, Li J et al.. (2014) Discovery of structurally novel, potent and orally efficacious GPR119 agonists.. Bioorg Med Chem Lett, 24 (10):(2383-7). [PMID:24751443]
2.Spasov AA, Kosolapov VA, Babkov DA, Maika OY. (2017) Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase.. Bull Exp Biol Med, 163 (5):(695-698). [PMID:28944428]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.